Bodal Chemicals Share Price
Sector: Chemical Manufacturing
75.92 +2.20 (2.98%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
73.49
Today’s High
77.28
52 Week Low
49.60
52 Week High
88.00
75.84 +2.02 (2.74%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
73.35
Today’s High
77.40
52 Week Low
50.01
52 Week High
87.85
Key Metrics
- Market Cap (In Cr) 956.17
- Beta 1.26
- Div. Yield (%) 0
- P/B 0.86
- TTM P/E 39.71
- Sector P/E 17.63
- D/E 0.01
- Open Price 74.45
- Prev Close 73.72
Bodal Chemicals Analysis
Price Analysis
-
1 Week11.89%
-
3 Months29.93%
-
6 Month11.69%
-
YTD12.81%
-
1 Year-2.37%
Risk Meter
- 48% Low risk
- 48% Moderate risk
- 48% Balanced Risk
- 48% High risk
- 48% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Buy
- 1
- 1
- 1
- 1
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 1
- 1
- 1
- 1
Bodal Chemicals News
Recommended stocks to buy today, 20 June, by India's leading market experts
10 min read . 20 Jun 2025Best stocks to buy today—recommended by NeoTrader's Raja Venkatraman
4 min read . 20 Jun 2025SMIFS stock picks: Rain Industries, Tata Steel, and more for short to long-term
3 min read . 05 Sep 2024Bodal Chemicals Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 1744.94
- Selling/ General/ Admin Expenses Total
- 114.85
- Depreciation/ Amortization
- 68.51
- Other Operating Expenses Total
- 577.02
- Total Operating Expense
- 1655.83
- Operating Income
- 89.1
- Net Income Before Taxes
- 19.31
- Net Income
- 18.5
- Diluted Normalized EPS
- 2.2
- Period
- 2025
- Total Assets
- 2352.9
- Total Liabilities
- 1248.06
- Total Equity
- 1104.85
- Tangible Book Valueper Share Common Eq
- 86.73
- Period
- 2025
- Cashfrom Operating Activities
- 112.58
- Cashfrom Investing Activities
- -37.01
- Cashfrom Financing Activities
- -73.46
- Net Changein Cash
- -0.47
- Period
- 2024
- Total Revenue
- 1394.62
- Selling/ General/ Admin Expenses Total
- 237.01
- Depreciation/ Amortization
- 60.49
- Other Operating Expenses Total
- 16.39
- Total Operating Expense
- 1344.21
- Operating Income
- 50.41
- Net Income Before Taxes
- 4.73
- Net Income
- 6.47
- Diluted Normalized EPS
- 0.06
- Period
- 2024
- Total Assets
- 2287.88
- Total Liabilities
- 1205.64
- Total Equity
- 1082.24
- Tangible Book Valueper Share Common Eq
- 84.96
- Period
- 2024
- Cashfrom Operating Activities
- 189.12
- Cashfrom Investing Activities
- -261.64
- Cashfrom Financing Activities
- 80.98
- Net Changein Cash
- 7.11
- Period
- 2023
- Total Revenue
- 1574.28
- Selling/ General/ Admin Expenses Total
- 255.81
- Depreciation/ Amortization
- 53.09
- Total Operating Expense
- 1489.26
- Operating Income
- 85.02
- Net Income Before Taxes
- 50.84
- Net Income
- 38.03
- Diluted Normalized EPS
- 2.95
- Period
- 2023
- Total Assets
- 2120.9
- Total Liabilities
- 1043.2
- Total Equity
- 1077.7
- Tangible Book Valueper Share Common Eq
- 84.63
- Period
- 2023
- Cashfrom Operating Activities
- 284.91
- Cashfrom Investing Activities
- -310.06
- Cashfrom Financing Activities
- 32.66
- Net Changein Cash
- 7.5
- Period
- 2022
- Total Revenue
- 2050.62
- Selling/ General/ Admin Expenses Total
- 110.46
- Depreciation/ Amortization
- 46.62
- Other Operating Expenses Total
- 567.56
- Total Operating Expense
- 1896.44
- Operating Income
- 154.18
- Net Income Before Taxes
- 142.05
- Net Income
- 104.23
- Diluted Normalized EPS
- 9.34
- Period
- 2022
- Total Assets
- 2122.31
- Total Liabilities
- 1066.51
- Total Equity
- 1055.8
- Tangible Book Valueper Share Common Eq
- 84.94
- Period
- 2022
- Cashfrom Operating Activities
- -13.52
- Cashfrom Investing Activities
- -170.29
- Cashfrom Financing Activities
- 181.2
- Net Changein Cash
- -2.61
- Period
- 2021
- Total Revenue
- 1226.43
- Selling/ General/ Admin Expenses Total
- 200.01
- Depreciation/ Amortization
- 30.49
- Other Operating Expenses Total
- 14.24
- Total Operating Expense
- 1166.07
- Operating Income
- 60.37
- Net Income Before Taxes
- 55.38
- Net Income
- 41.98
- Diluted Normalized EPS
- 3.43
- Period
- 2021
- Total Assets
- 1755.42
- Total Liabilities
- 774
- Total Equity
- 981.42
- Tangible Book Valueper Share Common Eq
- 78.88
- Period
- 2021
- Cashfrom Operating Activities
- -13.02
- Cashfrom Investing Activities
- -167.66
- Cashfrom Financing Activities
- 178.12
- Net Changein Cash
- -2.55
- Period
- 2020
- Total Revenue
- 1374.82
- Selling/ General/ Admin Expenses Total
- 191.65
- Depreciation/ Amortization
- 27.82
- Other Operating Expenses Total
- 11.38
- Total Operating Expense
- 1253.19
- Operating Income
- 121.63
- Net Income Before Taxes
- 101.22
- Net Income
- 87.63
- Diluted Normalized EPS
- 6.17
- Period
- 2020
- Total Assets
- 1470.71
- Total Liabilities
- 539.37
- Total Equity
- 931.34
- Tangible Book Valueper Share Common Eq
- 74.7
- Period
- 2020
- Cashfrom Operating Activities
- 11.28
- Cashfrom Investing Activities
- -80.51
- Cashfrom Financing Activities
- 75.91
- Net Changein Cash
- 6.68
- Period
- 2019
- Total Revenue
- 1423.5
- Selling/ General/ Admin Expenses Total
- 159.7
- Depreciation/ Amortization
- 21.25
- Other Operating Expenses Total
- 8.25
- Total Operating Expense
- 1206.21
- Operating Income
- 217.29
- Net Income Before Taxes
- 219.17
- Net Income
- 143.2
- Diluted Normalized EPS
- 11.72
- Period
- 2019
- Total Assets
- 1298.66
- Total Liabilities
- 469.3
- Total Equity
- 829.36
- Tangible Book Valueper Share Common Eq
- 67.64
- Period
- 2019
- Cashfrom Operating Activities
- 185.97
- Cashfrom Investing Activities
- -128.16
- Cashfrom Financing Activities
- -51.21
- Net Changein Cash
- 6.61
- Period
- 2025-03-31
- Total Revenue
- 450.87
- Selling/ General/ Admin Expenses Total
- 29.08
- Depreciation/ Amortization
- 17.01
- Other Operating Expenses Total
- 154.91
- Total Operating Expense
- 420.63
- Operating Income
- 30.24
- Net Income Before Taxes
- 11.6
- Net Income
- 14.5
- Diluted Normalized EPS
- 1.27
- Period
- 2025-03-31
- Total Assets
- 2352.9
- Total Liabilities
- 1248.06
- Total Equity
- 1104.85
- Tangible Book Valueper Share Common Eq
- 86.73
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 112.58
- Cashfrom Investing Activities
- -37.01
- Cashfrom Financing Activities
- -73.46
- Net Changein Cash
- -0.47
- Period
- 2024-12-31
- Total Revenue
- 443.47
- Selling/ General/ Admin Expenses Total
- 29.42
- Depreciation/ Amortization
- 17.26
- Other Operating Expenses Total
- 152.35
- Total Operating Expense
- 417.48
- Operating Income
- 25.98
- Net Income Before Taxes
- 8.18
- Net Income
- 5.42
- Diluted Normalized EPS
- 0.58
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 428.63
- Selling/ General/ Admin Expenses Total
- 28.13
- Depreciation/ Amortization
- 17.2
- Other Operating Expenses Total
- 137.82
- Total Operating Expense
- 413.18
- Operating Income
- 15.46
- Net Income Before Taxes
- 0.99
- Net Income
- -0.24
- Diluted Normalized EPS
- 0.08
- Period
- 2024-09-30
- Total Assets
- 2228.71
- Total Liabilities
- 1145.83
- Total Equity
- 1082.89
- Tangible Book Valueper Share Common Eq
- 84.95
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 112.29
- Cashfrom Investing Activities
- -11.77
- Cashfrom Financing Activities
- -109.2
- Net Changein Cash
- -10.99
- Period
- 2024-06-30
- Total Revenue
- 421.96
- Selling/ General/ Admin Expenses Total
- 28.21
- Depreciation/ Amortization
- 17.03
- Other Operating Expenses Total
- 131.94
- Total Operating Expense
- 404.55
- Operating Income
- 17.42
- Net Income Before Taxes
- -1.45
- Net Income
- -1.18
- Diluted Normalized EPS
- 0.03
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 393.59
- Selling/ General/ Admin Expenses Total
- 26.22
- Depreciation/ Amortization
- 17.01
- Other Operating Expenses Total
- 130.81
- Total Operating Expense
- 369.48
- Operating Income
- 24.11
- Net Income Before Taxes
- -2.06
- Net Income
- 2.04
- Diluted Normalized EPS
- 0.17
- Period
- 2024-03-31
- Total Assets
- 2287.88
- Total Liabilities
- 1205.64
- Total Equity
- 1082.24
- Tangible Book Valueper Share Common Eq
- 84.96
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 189.12
- Cashfrom Investing Activities
- -261.64
- Cashfrom Financing Activities
- 80.98
- Net Changein Cash
- 7.11
- Period
- 2023-12-31
- Total Revenue
- 338.55
- Selling/ General/ Admin Expenses Total
- 27.31
- Depreciation/ Amortization
- 14.52
- Other Operating Expenses Total
- 122.37
- Total Operating Expense
- 329.19
- Operating Income
- 9.36
- Net Income Before Taxes
- 1.91
- Net Income
- 0.98
- Diluted Normalized EPS
- 0.08
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Bodal Chemicals Technical
Moving Average
SMA
- 5 Day71.33
- 10 Day70.84
- 20 Day72.54
- 50 Day71.17
- 100 Day66.07
- 300 Day70.45
Bodal Chemicals Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Shree Pushkar Chemical & Ferti
- 331.9
- 21.8
- 7.03
- 384.5
- 195
- 1078.33
- Tuticorin Alkali Chem And Fertil
- 80
- -0.01
- -0.01
- 112
- 72
- 974.81
- Bodal Chemicals
- 75.92
- 2.2
- 2.98
- 88
- 49.6
- 956.17
- Transpek Industry
- 1647
- 23.1
- 1.42
- 1896
- 1100.05
- 916.5
- Zuari Agro Chemicals
- 211.05
- 0.05
- 0.02
- 268
- 152
- 884.07
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Shree Pushkar Chemical & Ferti
- 17.04
- 1.86
- 10.49
- 6.88
- Tuticorin Alkali Chem And Fertil
- 22.02
- 6.9
- -
- 10.21
- Bodal Chemicals
- 33.62
- 0.84
- 4.01
- 2.52
- Transpek Industry
- 18.61
- 1.23
- 9.73
- 8.66
- Zuari Agro Chemicals
- 5.39
- 0.48
- 18.23
- 5.98
Bodal Chemicals Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 27-May-25
- Audited Results
- 10-Feb-25
- Quarterly Results & Others
- 14-Nov-24
- Quarterly Results & Others
- 14-Aug-24
- Quarterly Results & A.G.M.
- 24-May-24
- Audited Results
- 06-Mar-24
- Preferential issue of shares
- 13-Feb-24
- Quarterly Results
- 06-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results & A.G.M.
- 30-May-23
- Audited Results & Final Dividend
- Meeting Date
- Announced on
- Purpose
- 24-Sept-24
- 27-Aug-24
- AGM
- 22-Aug-24
- 18-Jul-24
- POM
- 03-Apr-24
- 11-Mar-24
- EGM
- 28-Sept-23
- 25-Aug-23
- AGM
- 21-Jul-22
- 16-Jun-22
- COM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 30-May-23
- -
- 22-Sept-23
- 0.1
- 27-May-22
- -
- 22-Sept-22
- 0.8
- 24-Jun-21
- -
- 16-Sept-21
- 0.8


